Helix Biopharma Corp Stock Technical Analysis
| HBP Stock | CAD 0.77 0.07 10.00% |
As of the 23rd of November, Helix BioPharma retains the Risk Adjusted Performance of (0.01), market risk adjusted performance of 0.1498, and Standard Deviation of 8.05. Helix BioPharma technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Helix BioPharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Helix, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to HelixHelix |
Helix BioPharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Helix BioPharma Corp Technical Analysis
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Helix BioPharma Corp volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Helix BioPharma Corp Trend Analysis
Use this graph to draw trend lines for Helix BioPharma Corp. You can use it to identify possible trend reversals for Helix BioPharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Helix BioPharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Helix BioPharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Helix BioPharma Corp applied against its price change over selected period. The best fit line has a slop of 0.01 , which may suggest that Helix BioPharma Corp market price will keep on failing further. It has 122 observation points and a regression sum of squares at 5.17, which is the sum of squared deviations for the predicted Helix BioPharma price change compared to its average price change.About Helix BioPharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Helix BioPharma Corp on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Helix BioPharma Corp based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Helix BioPharma Corp price pattern first instead of the macroeconomic environment surrounding Helix BioPharma Corp. By analyzing Helix BioPharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Helix BioPharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Helix BioPharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Payables Turnover | 0.0164 | 0.0156 | Days Of Inventory On Hand | 4.5K | 4.7K |
Helix BioPharma November 23, 2024 Technical Indicators
Most technical analysis of Helix help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Helix from various momentum indicators to cycle indicators. When you analyze Helix charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | 0.1498 | |||
| Mean Deviation | 5.07 | |||
| Coefficient Of Variation | (3,281) | |||
| Standard Deviation | 8.05 | |||
| Variance | 64.76 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | (1.52) | |||
| Treynor Ratio | 0.1398 | |||
| Maximum Drawdown | 46.6 | |||
| Value At Risk | (10.62) | |||
| Potential Upside | 9.35 | |||
| Skewness | 2.13 | |||
| Kurtosis | 10.16 |
Other Information on Investing in Helix Stock
Helix BioPharma financial ratios help investors to determine whether Helix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Helix with respect to the benefits of owning Helix BioPharma security.